Potts Jeannette
Chief Legal Officer at QURE; Officer at Forma Therapeutics Holdings, Inc.,
- Sold, on record
- $474k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jun 15, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- QUREuniQure N.V.Chief Legal Officer
- Forma Therapeutics Holdings, Inc.,Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- QURE33,754 shares
- Forma Therapeutics Holdings, Inc.,4,672 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Forma Therapeutics Holdings, Inc.,Plan not statedFeb 23, 2022 2022
Sold 4,672 shares at $9.78 ($46k)
Potts Jeannette, Officer
Sold 17.3% of holdings ($264k position)22,358 shares leftFirst sale on recordFiling
- 2 Form 4 sale QURENo planJun 13, 2024 +841 days
Sold 4,781 shares at $4.98 ($24k)
Potts Jeannette, Chief Legal Officer
No 10b5-1 planSold 4.9% of holdings ($481k position)91,819 shares leftFirst sale on recordFiling
- 3 Form 4 sale QURENo planMar 4, 2025 +264 days
Sold 7,076 shares at $10.29 ($73k)
Potts Jeannette, Chief Legal Officer
No 10b5-1 planSold 5.6% of holdings ($1.3M position)119,743 shares leftFiling
- 4 Form 4 sale QURENo planJun 16, 2025 +104 days
Sold 4,670 shares at $15.14 ($71k)
Potts Jeannette, Chief Legal Officer
No 10b5-1 planSold 3.9% of holdings ($1.8M position)115,073 shares leftFiling
- 5 Form 4 sale QURENo planMar 2, 2026 +259 days
Sold 8,578 shares at $9.95 ($85k)
Potts Jeannette, Chief Legal Officer
No 10b5-1 planSold 7.5% of holdings ($1.1M position)106,495 shares left1.8x usual sizeFiling
- 6 Form 4 sale QURENo planMar 4, 2026 +2 days
Sold 3,412 shares at $9.06 ($31k)
Potts Jeannette, Chief Legal Officer
No 10b5-1 planSold 2.4% of holdings ($1.3M position)138,483 shares left0.6x usual sizeFiling
- 7 Form 4 sale QURENo planJun 15, 2026 +103 days
Sold 5,237 shares at $27.67 ($145k)
Potts Jeannette, Chief Legal Officer
No 10b5-1 planSold 3.8% of holdings ($3.8M position)133,246 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17, 2026 | QURE | Chief Legal Officer | Form 4 sale | 5,237 | $145k | 3.8% | No plan | SEC |
| Mar 4, 2026 | Mar 6, 2026 | QURE | Chief Legal Officer | Form 4 sale | 3,412 | $31k | 2.4% | No plan | SEC |
| Mar 2, 2026 | Mar 4, 2026 | QURE | Chief Legal Officer | Form 4 sale | 8,578 | $85k | 7.5% | No plan | SEC |
| Jun 16, 2025 | Jun 20, 2025 | QURE | Chief Legal Officer | Form 4 sale | 4,670 | $71k | 3.9% | No plan | SEC |
| Mar 4, 2025 | Mar 5, 2025 | QURE | Chief Legal Officer | Form 4 sale | 7,076 | $73k | 5.6% | No plan | SEC |
| Jun 13, 2024 | Jun 17, 2024 | QURE | Chief Legal Officer | Form 4 sale | 4,781 | $24k | 4.9% | No plan | SEC |
| Feb 23, 2022 | Feb 25, 2022 | Forma Therapeutics Holdings, Inc., | Officer | Form 4 sale | 4,672 | $46k | 17.3% | Plan not stated | SEC |